Cisplatin Exposure of Squamous Cell Carcinoma Cells Leads to Modulation of the Autophagic Pathway

Rafael Guerrero-Preston, Edward A. Ratovitski

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Platinum chemotherapy is beneficial for human epithelial cancers because the platinum agents induce DNA damage signaling, leading to initiation of cell cycle arrest and apoptosis, and ultimately to tumor cell death. However, tumor cells often develop chemoresistance to platinum anticancer drugs, because of the initiation of autophagic pathways serving as a cell-protective mechanism against these chemical stresses. Although the molecular events underlying these events are not yet completely understood, the critical role of tumor protein (TP)-p53 family members, as key players in guarding the genome and proteome integrity under stress, is very much appreciated. As transcriptional factors, TP53 members exert their functions through the transcriptional regulation of genes encoding the autophagic intermediates, while also affecting the transcription of microRNA by inducing or reducing their expression in tumor cells sensitive or resistant to chemotherapeutic anticancer drugs. These microRNAs subsequently modulate the expression of autophagic proteins and are very likely to change the molecular landscape of tumor-cell response to the anticancer drugs. Thus, a clear and in-depth understanding of molecular pathways leading to modulation of autophagic intermediates through transcription, microRNA modulation, and protein-protein interactions would lead to potentially beneficial adjustments of existing chemotherapeutics supplemented with small molecule- or microRNA-based regimens.

Original languageEnglish (US)
Title of host publicationMolecular Mechanisms
PublisherElsevier Inc.
Pages251-267
Number of pages17
Volume1
ISBN (Print)9780124055353, 9780124055308
DOIs
StatePublished - Aug 22 2013

Fingerprint

Cisplatin
Squamous Cell Carcinoma
MicroRNAs
Platinum
Neoplasms
Proteins
Social Adjustment
Proteome
Cell Cycle Checkpoints
Pharmaceutical Preparations
Antineoplastic Agents
DNA Damage
Cell Death
Genome
Apoptosis
Drug Therapy
Genes

Keywords

  • Autophagic signaling
  • Chemoresistance
  • Cisplatin
  • Platinum chemotherapy
  • Tumor protein (TP)-p53

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Guerrero-Preston, R., & Ratovitski, E. A. (2013). Cisplatin Exposure of Squamous Cell Carcinoma Cells Leads to Modulation of the Autophagic Pathway. In Molecular Mechanisms (Vol. 1, pp. 251-267). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-405530-8.00017-0

Cisplatin Exposure of Squamous Cell Carcinoma Cells Leads to Modulation of the Autophagic Pathway. / Guerrero-Preston, Rafael; Ratovitski, Edward A.

Molecular Mechanisms. Vol. 1 Elsevier Inc., 2013. p. 251-267.

Research output: Chapter in Book/Report/Conference proceedingChapter

Guerrero-Preston, R & Ratovitski, EA 2013, Cisplatin Exposure of Squamous Cell Carcinoma Cells Leads to Modulation of the Autophagic Pathway. in Molecular Mechanisms. vol. 1, Elsevier Inc., pp. 251-267. https://doi.org/10.1016/B978-0-12-405530-8.00017-0
Guerrero-Preston R, Ratovitski EA. Cisplatin Exposure of Squamous Cell Carcinoma Cells Leads to Modulation of the Autophagic Pathway. In Molecular Mechanisms. Vol. 1. Elsevier Inc. 2013. p. 251-267 https://doi.org/10.1016/B978-0-12-405530-8.00017-0
Guerrero-Preston, Rafael ; Ratovitski, Edward A. / Cisplatin Exposure of Squamous Cell Carcinoma Cells Leads to Modulation of the Autophagic Pathway. Molecular Mechanisms. Vol. 1 Elsevier Inc., 2013. pp. 251-267
@inbook{16e619f98703477899dadd3701de280f,
title = "Cisplatin Exposure of Squamous Cell Carcinoma Cells Leads to Modulation of the Autophagic Pathway",
abstract = "Platinum chemotherapy is beneficial for human epithelial cancers because the platinum agents induce DNA damage signaling, leading to initiation of cell cycle arrest and apoptosis, and ultimately to tumor cell death. However, tumor cells often develop chemoresistance to platinum anticancer drugs, because of the initiation of autophagic pathways serving as a cell-protective mechanism against these chemical stresses. Although the molecular events underlying these events are not yet completely understood, the critical role of tumor protein (TP)-p53 family members, as key players in guarding the genome and proteome integrity under stress, is very much appreciated. As transcriptional factors, TP53 members exert their functions through the transcriptional regulation of genes encoding the autophagic intermediates, while also affecting the transcription of microRNA by inducing or reducing their expression in tumor cells sensitive or resistant to chemotherapeutic anticancer drugs. These microRNAs subsequently modulate the expression of autophagic proteins and are very likely to change the molecular landscape of tumor-cell response to the anticancer drugs. Thus, a clear and in-depth understanding of molecular pathways leading to modulation of autophagic intermediates through transcription, microRNA modulation, and protein-protein interactions would lead to potentially beneficial adjustments of existing chemotherapeutics supplemented with small molecule- or microRNA-based regimens.",
keywords = "Autophagic signaling, Chemoresistance, Cisplatin, Platinum chemotherapy, Tumor protein (TP)-p53",
author = "Rafael Guerrero-Preston and Ratovitski, {Edward A.}",
year = "2013",
month = "8",
day = "22",
doi = "10.1016/B978-0-12-405530-8.00017-0",
language = "English (US)",
isbn = "9780124055353",
volume = "1",
pages = "251--267",
booktitle = "Molecular Mechanisms",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Cisplatin Exposure of Squamous Cell Carcinoma Cells Leads to Modulation of the Autophagic Pathway

AU - Guerrero-Preston, Rafael

AU - Ratovitski, Edward A.

PY - 2013/8/22

Y1 - 2013/8/22

N2 - Platinum chemotherapy is beneficial for human epithelial cancers because the platinum agents induce DNA damage signaling, leading to initiation of cell cycle arrest and apoptosis, and ultimately to tumor cell death. However, tumor cells often develop chemoresistance to platinum anticancer drugs, because of the initiation of autophagic pathways serving as a cell-protective mechanism against these chemical stresses. Although the molecular events underlying these events are not yet completely understood, the critical role of tumor protein (TP)-p53 family members, as key players in guarding the genome and proteome integrity under stress, is very much appreciated. As transcriptional factors, TP53 members exert their functions through the transcriptional regulation of genes encoding the autophagic intermediates, while also affecting the transcription of microRNA by inducing or reducing their expression in tumor cells sensitive or resistant to chemotherapeutic anticancer drugs. These microRNAs subsequently modulate the expression of autophagic proteins and are very likely to change the molecular landscape of tumor-cell response to the anticancer drugs. Thus, a clear and in-depth understanding of molecular pathways leading to modulation of autophagic intermediates through transcription, microRNA modulation, and protein-protein interactions would lead to potentially beneficial adjustments of existing chemotherapeutics supplemented with small molecule- or microRNA-based regimens.

AB - Platinum chemotherapy is beneficial for human epithelial cancers because the platinum agents induce DNA damage signaling, leading to initiation of cell cycle arrest and apoptosis, and ultimately to tumor cell death. However, tumor cells often develop chemoresistance to platinum anticancer drugs, because of the initiation of autophagic pathways serving as a cell-protective mechanism against these chemical stresses. Although the molecular events underlying these events are not yet completely understood, the critical role of tumor protein (TP)-p53 family members, as key players in guarding the genome and proteome integrity under stress, is very much appreciated. As transcriptional factors, TP53 members exert their functions through the transcriptional regulation of genes encoding the autophagic intermediates, while also affecting the transcription of microRNA by inducing or reducing their expression in tumor cells sensitive or resistant to chemotherapeutic anticancer drugs. These microRNAs subsequently modulate the expression of autophagic proteins and are very likely to change the molecular landscape of tumor-cell response to the anticancer drugs. Thus, a clear and in-depth understanding of molecular pathways leading to modulation of autophagic intermediates through transcription, microRNA modulation, and protein-protein interactions would lead to potentially beneficial adjustments of existing chemotherapeutics supplemented with small molecule- or microRNA-based regimens.

KW - Autophagic signaling

KW - Chemoresistance

KW - Cisplatin

KW - Platinum chemotherapy

KW - Tumor protein (TP)-p53

UR - http://www.scopus.com/inward/record.url?scp=84942872867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942872867&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-405530-8.00017-0

DO - 10.1016/B978-0-12-405530-8.00017-0

M3 - Chapter

AN - SCOPUS:84942872867

SN - 9780124055353

SN - 9780124055308

VL - 1

SP - 251

EP - 267

BT - Molecular Mechanisms

PB - Elsevier Inc.

ER -